News
Grok 4 made repeated blunders, while o3 played steady ...
8h
Zacks Investment Research on MSNOpus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates
Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.3 per share a year ago. These figures ...
9h
TipRanks on MSNOpus Genetics reports Q2 EPS (12c) vs (30c) last year
Reports Q2 revenue $2.9M, consensus $4.27M. “We’ve made significant progress across our pipeline, with multiple clinical and regulatory milestones ...
In a way, AI models launder human responsibility and human agency through their complexity. When outputs emerge from layers of neural networks processing billions of parameters, researchers can claim ...
Alicia Witt reflects on working with Richard Dreyfuss in “Mr. Holland’s Opus,” praising his kindness toward young actors.
Allstate says an email circulating that claims it has a pricing agreement with two tool companies for calibrations is false. ...
The minor twist here is that neither Campbell nor Collins actually has a book deal: Politics and Prose isn’t just selling the ...
Claude Sonnet 4 has been upgraded, and it can now remember up to 1 million tokens of context, but only when it's used via API ...
A tech startup wants to replace traditional cement with an eco-friendly alternative, and it just secured the funding to move ...
AI writing tools ChatGPT 5 and Claude 4.1 Opus go head-to-head. Explore their strengths, weaknesses, and which one suits your ...
OpenAI’s new flagship AI model, GPT-5, crushes coding tests and complex logic, but lags behind rivals like Claude in creative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results